GeneOne Life Science, Inc.
Biopharmaceutical R&D company specializing in nucleic acid-based biomedicines.
011000 | KO
Overview
Corporate Details
- ISIN(s):
- KR7011000007
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 영등포구 여의대로 108 20층(여의도동, 파크원NH금융타워(타워2)), 서울특별시
- Website:
- https://www.genels.com/en/
Description
GeneOne Life Science, Inc. is a biopharmaceutical research and development company specializing in nucleic acid-based biomedicines. The company's core focus is on developing DNA and mRNA vaccines, particularly for emerging infectious diseases, leveraging its rapid development platforms. In therapeutics, GeneOne utilizes a proprietary DNA plasmid delivery technology to enable the expression of recombinant proteins and plasmid-encoded monoclonal antibodies (Plas-mAbs®). This non-viral vector approach is designed to offer a safer and more cost-effective alternative to traditional gene therapies and cell-line derived monoclonal antibody treatments for conditions such as cancers and autoimmune disorders. The company also develops immunomodulatory small molecule drugs. Through its subsidiary, GeneOne possesses cGMP-grade manufacturing capabilities for DNA plasmids, supporting its internal pipeline and contract manufacturing services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-09 00:00 |
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 13.6 KB | ||
| 2025-09-08 00:00 |
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 15.9 KB | ||
| 2025-09-04 00:00 |
소액공모실적보고서
|
Korean | 25.7 KB | ||
| 2025-09-04 00:00 |
유상증자또는주식관련사채등의발행결과(자율공시)
|
Korean | 7.5 KB | ||
| 2025-09-03 00:00 |
유상증자또는주식관련사채등의청약결과(자율공시)
|
Korean | 7.1 KB | ||
| 2025-08-29 00:00 |
소액공모공시서류(지분증권)
|
Korean | 1.9 MB | ||
| 2025-08-29 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 49.7 KB | ||
| 2025-08-29 00:00 |
유상증자신주발행가액(안내공시)
|
Korean | 4.2 KB | ||
| 2025-08-22 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 36.6 KB | ||
| 2025-08-20 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-08-20 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 102.7 KB | ||
| 2025-08-20 00:00 |
최대주주등소유주식변동신고서
|
Korean | 34.7 KB | ||
| 2025-08-14 00:00 |
반기보고서 (2025.06)
|
Korean | 1.9 MB | ||
| 2025-08-14 00:00 |
[기재정정]사업보고서 (2024.12)
|
Korean | 2.3 MB | ||
| 2025-08-12 00:00 |
임시주주총회결과
|
Korean | 29.1 KB |
Automate Your Workflow. Get a real-time feed of all GeneOne Life Science, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GeneOne Life Science, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GeneOne Life Science, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
